Recombinant Bacillus subtilis uncharacterized protein YpbF (YpbF) is a protein expressed in E. coli and fused to an N-terminal His tag . The full-length protein consists of 147 amino acids . The molecular mass of YpbF is approximately 16.4 kDa, and its theoretical isoelectric point (pI) is 9.44 .
| Feature | Description |
|---|---|
| Source | E. coli |
| Tag | His tag (N-terminal) |
| Protein Length | Full Length (1-147 amino acids) |
| Amino Acid Sequence | MESLWNQLDQFTDAPTKQMLQALVKRKQKFENYAAQCRRWRWASLICLGLLCVMIMIKSP EPQLILQEILSHTFYLFWMLATAFAYCTSYYFKKKEEKSETDFHKLRCEIIQKSTDLWPQ PDKWKARESVFHMMKHKYDINLYFESK |
| Purity | Greater than 90% as determined by SDS-PAGE |
| Applications | SDS-PAGE |
| Synonyms | ypbF; BSU22990; Uncharacterized protein YpbF |
| UniProt ID | P50732 |
| Storage Buffer | Tris/PBS-based buffer, 6% Trehalose, pH 8.0 |
The precise biological role and function of YpbF in Bacillus subtilis remain uncharacterized . Proteins designated as "uncharacterized" often represent novel targets for further research to elucidate their specific roles within the organism . Further studies, including structural analysis, interaction studies, and genetic experiments, could provide insights into the function of YpbF in Bacillus subtilis .
Bacillus subtilis is used to express recombinant proteins. For example, a recombinant Bacillus subtilis strain was engineered to express porcine β-defensin-2 (pBD-2) and cecropin P1 (CP1) fusion antimicrobial peptide. The engineered B. subtilis expressed the pBD-2/CP1 fusion peptide efficiently, which showed antimicrobial activities against various bacteria . Supplementing pig feed with the engineered B. subtilis significantly promoted piglet growth and reduced diarrhea incidence .
KEGG: bsu:BSU22990
STRING: 224308.Bsubs1_010100012631
The ypbF protein from Bacillus subtilis remains largely uncharacterized in current literature. It is categorized as a hypothetical protein with unknown function in the B. subtilis proteome. Researchers working with this protein typically utilize recombinant expression systems to produce sufficient quantities for functional and structural characterization studies . Due to its uncharacterized nature, determining its biological role requires comprehensive experimental approaches including sequence analysis, structural studies, and functional assays.
For optimal expression of recombinant B. subtilis ypbF protein, several expression systems can be employed depending on research objectives:
Homologous expression: Using modified B. subtilis strains as expression hosts often provides proper protein folding and potential post-translational modifications relevant to the native environment .
Heterologous expression: E. coli-based systems (particularly BL21(DE3) derivatives) are commonly used for high-yield production, though proper folding may require optimization .
Secretion-based expression: For proteins that may be naturally secreted, utilizing B. subtilis secretion pathways with optimized signal peptides can enhance purification efficiency .
The choice of expression system should be guided by the intended downstream applications. For structural studies requiring high purity and yield, E. coli systems may be preferable, while functional studies might benefit from homologous expression in B. subtilis to maintain native interactions and modifications.
When studying uncharacterized proteins such as ypbF, multiple bioinformatic approaches can provide valuable insights:
Sequence homology analysis: Comparing the amino acid sequence against characterized proteins using tools like BLAST to identify conserved domains or homologous proteins with known functions.
Structural prediction: Using programs like AlphaFold or I-TASSER to predict three-dimensional structure, which may provide functional clues based on structural similarities.
Genomic context analysis: Examining the location of the ypbF gene in the B. subtilis genome and its proximity to other genes may suggest involvement in specific pathways.
Transcriptomic correlation: Analyzing under which conditions the ypbF gene is co-expressed with other genes of known function to infer potential physiological roles.
Conserved domain identification: Searching for recognized functional domains using databases like Pfam or InterPro.
These computational approaches should guide subsequent experimental design rather than serving as definitive functional assignments.
Designing effective gene knockout and complementation studies for ypbF requires a systematic approach:
Knockout Strategy:
Create a clean deletion of the ypbF gene using homologous recombination in B. subtilis, preserving reading frames of adjacent genes .
Verify deletion by PCR and sequencing to confirm complete removal without polar effects.
Subject the knockout strain to comprehensive phenotypic analysis under various growth conditions (different media, stressors, carbon sources) to identify conditions where the mutant displays altered phenotypes.
Complementation Testing:
Reintroduce the ypbF gene under control of both its native promoter and inducible promoters at ectopic chromosomal locations (such as the amyE locus) .
Include epitope-tagged versions for localization studies.
Perform rescue experiments under conditions where the knockout exhibited phenotypes.
Controls:
Include the wild-type strain carrying the same antibiotic resistance marker.
Add a strain with complementation using a site-directed mutant of ypbF with alterations in predicted functional residues.
This comprehensive approach can distinguish between direct and indirect effects of ypbF deletion, providing stronger evidence for its physiological role.
For identifying protein-protein interactions involving the uncharacterized ypbF protein, multiple complementary approaches should be employed:
In vivo methods:
Bacterial two-hybrid assays: Adapt systems like BACTH (Bacterial Adenylate Cyclase Two-Hybrid) for B. subtilis proteins to screen for potential interactors.
Co-immunoprecipitation with epitope-tagged ypbF expressed at physiological levels, followed by mass spectrometry identification of binding partners.
Proximity-dependent biotin labeling (BioID or TurboID) fused to ypbF to identify proteins in close proximity in vivo.
In vitro methods:
Pull-down assays using purified recombinant ypbF as bait against B. subtilis cell lysates.
Surface plasmon resonance (SPR) or isothermal titration calorimetry (ITC) to quantify binding parameters with candidate interactors.
Validation approaches:
Reciprocal co-immunoprecipitation of detected interactors.
Fluorescence co-localization studies using fluorescently tagged proteins.
Functional assays to assess the biological relevance of identified interactions.
Combining these methods provides a robust framework for building an interaction network around ypbF, potentially revealing its functional context within cellular processes.
Determining the subcellular localization of ypbF requires multiple complementary approaches to ensure reliable results:
Fluorescent protein fusion strategies:
C-terminal and N-terminal GFP/mCherry fusions expressed from native genomic loci to preserve physiological expression levels.
Verification that fusion proteins retain functionality through complementation tests in a ypbF deletion strain.
Time-lapse microscopy to track localization changes during cell cycle progression or stress responses.
Immunolocalization approaches:
Generation of specific antibodies against purified recombinant ypbF protein.
Immunofluorescence microscopy using fixed B. subtilis cells with appropriate permeabilization protocols.
Immunogold labeling combined with electron microscopy for higher resolution localization.
Subcellular fractionation:
Separation of membrane, cytoplasmic, and nucleoid fractions.
Western blot analysis of fractions using anti-ypbF antibodies or detection of epitope tags.
Verification with established marker proteins for each cellular compartment.
These approaches should be performed under different growth conditions and stress situations to capture condition-dependent localization patterns that might provide functional insights.
Based on the known stress response mechanisms in B. subtilis, researchers should systematically test the following conditions when investigating ypbF function:
| Stress Category | Specific Conditions | Assessment Methods |
|---|---|---|
| Osmotic stress | 0.4M-1.2M NaCl, KCl, Sucrose | Growth curves, survival rates, protein expression levels |
| Oxidative stress | H₂O₂, paraquat, diamide | ROS detection, survival assays, enzyme activity |
| Nutrient limitation | Carbon, nitrogen, phosphate starvation | Growth kinetics, sporulation efficiency |
| Temperature stress | Heat shock (42-50°C), Cold shock (15°C) | Viability, protein aggregation, chaperone activity |
| pH stress | Acidic (pH 5.0) and alkaline (pH 9.0) conditions | Internal pH homeostasis, membrane integrity |
| Cell wall stress | Vancomycin, bacitracin, lysozyme | Cell morphology, cell wall thickness |
| Secretion stress | Overexpression of secreted proteins | Secretion efficiency, CssRS pathway activation |
Comparing wild-type and ypbF deletion strains under these conditions may reveal phenotypic differences indicative of the protein's role. The approach used in the study of Bacillus subtilis CM66-P4' under fishing and starvation stress provides a methodological framework that could be adapted to study ypbF's potential stress response functions .
When designing transcriptomic studies to investigate the effects of ypbF deletion on gene expression in B. subtilis, consider this comprehensive approach:
Experimental design:
Compare three strains: wild-type, ypbF deletion mutant, and complemented strain.
Test multiple growth conditions, including standard laboratory conditions and those where phenotypic differences were observed.
Sample at multiple growth phases (early exponential, mid-exponential, transition, and stationary).
Technical considerations:
Use RNA-seq rather than microarrays for better detection of novel transcripts and splice variants.
Perform at least three biological replicates for statistical power.
Include spike-in controls for normalization and validation.
Data analysis pipeline:
Identify differentially expressed genes using appropriate statistical methods with FDR correction.
Perform gene ontology enrichment analysis to identify affected biological processes.
Validate key expression changes using RT-qPCR.
Integrate with existing B. subtilis regulatory network information.
Follow-up studies:
Investigate direct vs. indirect regulatory effects using chromatin immunoprecipitation if ypbF is suspected to have DNA-binding properties.
Confirm protein-level changes for key differentially expressed genes.
This approach will help establish whether ypbF has a regulatory role and identify cellular processes affected by its absence.
To investigate potential enzymatic activities of the uncharacterized ypbF protein, researchers should employ a systematic approach:
Initial screening assays:
General activity testing for common enzymatic classes:
Hydrolase activity (esterases, proteases, glycosidases)
Oxidoreductase activity (using various electron acceptors)
Transferase activity (phosphorylation, glycosylation, methylation)
Isomerase and lyase activities
Substrate identification:
Activity-based protein profiling using activity-based probes.
Metabolite profiling comparing wild-type and ypbF mutant strains.
In silico prediction of potential substrates based on structural modeling.
Detailed kinetic characterization:
Purification of recombinant ypbF to homogeneity.
Determination of kinetic parameters (Km, Vmax, kcat) for identified substrates.
Inhibition studies to confirm specificity.
Effect of pH, temperature, and ion concentrations on activity.
Structural studies to support function:
Site-directed mutagenesis of predicted catalytic residues.
X-ray crystallography or cryo-EM structure determination with and without substrates/inhibitors.
This methodical approach starts with broad screening before narrowing to specific activity characterization, maximizing the chances of identifying enzymatic function even if the activity is unconventional.
Proteomics offers powerful tools for uncovering the function of uncharacterized proteins like ypbF through multiple complementary approaches:
Comparative proteomics:
Compare the proteome of wild-type and ypbF deletion strains under various conditions using quantitative proteomics (SILAC, TMT, or label-free approaches).
Identify differentially abundant proteins and affected pathways that may indicate ypbF function.
Protein-protein interaction networks:
Immunoprecipitation coupled with mass spectrometry (IP-MS) using tagged ypbF as bait.
Crosslinking mass spectrometry (XL-MS) to capture transient interactions and structural information.
BioID or APEX proximity labeling to identify proteins in the same subcellular neighborhood.
Post-translational modifications:
Phosphoproteomics to determine if ypbF is phosphorylated or affects phosphorylation networks.
Analysis of other PTMs (acetylation, glycosylation, etc.) that might regulate ypbF function.
Protein turnover and dynamics:
Pulse-chase SILAC to measure protein synthesis and degradation rates in wild-type versus ypbF mutants.
Thermal proteome profiling to identify proteins whose thermal stability is affected by ypbF deletion.
These approaches, when integrated with transcriptomics and genetic data, can provide a comprehensive view of ypbF's role in cellular processes and guide targeted functional studies.
For comprehensive structural characterization of the uncharacterized ypbF protein, researchers should consider a multi-technique approach:
High-resolution structure determination:
X-ray crystallography: Provides atomic-level resolution if diffraction-quality crystals can be obtained.
Requires optimization of protein constructs and crystallization conditions.
Co-crystallization with potential binding partners or substrates may reveal functional sites.
Cryo-electron microscopy (cryo-EM): Particularly valuable if ypbF forms larger complexes.
Single-particle analysis for 3D reconstruction.
Does not require crystallization but may be challenging for smaller proteins.
Nuclear Magnetic Resonance (NMR) spectroscopy: Ideal for studying protein dynamics and interactions in solution.
Suitable for smaller proteins or domains (<30 kDa).
Can identify binding sites and conformational changes upon ligand binding.
Complementary structural techniques:
Small-angle X-ray scattering (SAXS): Provides low-resolution envelopes of protein shape in solution.
Hydrogen-deuterium exchange mass spectrometry (HDX-MS): Maps protein dynamics and solvent accessibility.
Circular dichroism (CD): Assesses secondary structure content and stability.
Thermal shift assays: Identifies conditions and ligands that stabilize the protein.
The choice between these methods should be guided by the size of ypbF, its biophysical properties, and specific research questions. Often, combining multiple techniques provides the most comprehensive understanding of protein structure and dynamics.
Designing effective CRISPR-Cas9 strategies for studying ypbF function in B. subtilis requires careful consideration of several factors:
Gene editing approaches:
Complete gene knockout:
Design sgRNAs targeting the beginning of the coding sequence to ensure complete loss of function.
Include homology-directed repair templates with selectable markers for efficient screening.
Verify deletions using sequencing to confirm clean edits without off-target effects.
Domain-specific mutations:
Target specific domains predicted through bioinformatic analysis.
Design repair templates with point mutations in catalytic or binding sites.
Include silent mutations in the PAM site to prevent re-cutting after editing.
Conditional knockdown:
Implement CRISPRi (CRISPR interference) using catalytically inactive Cas9 (dCas9) for temporally controlled gene repression.
Design sgRNAs targeting the promoter region or early coding sequence.
Use inducible promoters to control dCas9 expression for titratable repression.
Technical considerations for B. subtilis:
Optimize codon usage of Cas9 for expression in B. subtilis.
Use well-characterized inducible promoters like Pxyl or Pspac.
Consider genome integration versus plasmid-based expression systems.
Perform thorough off-target prediction analysis specific to the B. subtilis genome.
Validation and controls:
Include multiple sgRNAs targeting different regions of ypbF.
Generate complementation strains to confirm phenotypes are specifically due to ypbF disruption.
Sequence the entire genome of edited strains to identify potential off-target effects.
This comprehensive CRISPR-Cas9 approach allows for precise genetic manipulation to study ypbF function while minimizing confounding variables and off-target effects.
When encountering expression or solubility issues with recombinant ypbF protein, researchers should implement this systematic troubleshooting approach:
Expression optimization:
Test multiple expression systems:
Modify expression conditions:
Lower induction temperature (16-25°C)
Reduce inducer concentration for slower expression
Test rich versus minimal media
Optimize induction timing based on growth phase
Solubility enhancement strategies:
Protein engineering approaches:
Express individual domains rather than full-length protein
Remove predicted disordered regions
Create fusion proteins with solubility tags (MBP, SUMO, TrxA)
Buffer optimization:
Screen different pH conditions (pH 5.5-8.5)
Test various salt concentrations (50-500 mM)
Add stabilizing additives (glycerol, arginine, trehalose)
Include reducing agents if cysteine residues are present
Extraction methods:
Gentle lysis procedures to prevent aggregation
Inclusion body solubilization and refolding protocols
Extraction with mild detergents if membrane-associated
Analytical approaches:
Apply limited proteolysis to identify stable domains
Use thermal shift assays to identify stabilizing buffer conditions
Analyze sequence for hydrophobic regions that might affect solubility
This methodical approach addresses the most common causes of expression and solubility problems with recombinant proteins.
Genetic controls:
Complementation analysis:
Reintroduce the ypbF gene at an ectopic locus under native or inducible control.
Include both wild-type and catalytic mutant versions for functional domain analysis.
Verify restoration of wild-type phenotype with the complemented strain.
Multiple independent mutant clones:
Analyze several independently constructed deletion mutants to rule out secondary mutations.
Verify clean deletion boundaries by sequencing in all clones.
Marker effect controls:
Include a wild-type strain with the same antibiotic marker inserted at a neutral locus.
Ensure phenotypes are not due to marker insertion or antibiotic selection.
Experimental controls:
Growth condition standardization:
Ensure all strains are grown under identical conditions.
Standardize inoculum density and growth phase for experiments.
Polar effect evaluation:
Measure expression of flanking genes to ensure the deletion doesn't affect their expression.
Design deletions that preserve reading frames and regulatory elements of adjacent genes.
Stress response validation:
Include known stress response mutants as positive controls for specific assays.
Verify that general stress responses are intact in the ypbF mutant using established stress markers.
These controls help distinguish genuine ypbF-specific phenotypes from artifacts and provide stronger evidence for the protein's biological function.
Integrating diverse data types to build a comprehensive model of ypbF function requires a systematic, multi-layered approach:
Data integration framework:
Primary data layers:
Genomic context analysis (gene neighborhood, synteny across species)
Transcriptomic data (differential expression, co-expression networks)
Proteomic data (abundance changes, interaction networks, PTMs)
Metabolomic data (metabolite changes in deletion mutants)
Phenotypic data (growth, stress resistance, morphology)
Structural data (protein domains, binding sites, conformational states)
Integration strategies:
Network-based approaches merging protein-protein, genetic, and metabolic interactions
Machine learning algorithms to identify patterns across datasets
Bayesian statistical frameworks to weigh evidence from different sources
Pathway enrichment analyses across multiple data types
Validation approaches:
Hypothesis testing:
Generate specific, testable predictions from the integrated model
Design targeted experiments to validate key model components
Iteratively refine the model based on new experimental results
Cross-species comparison:
Test if orthologous proteins in related species have similar functions
Use evolutionary conservation patterns to prioritize functional elements
Visualization and sharing:
Develop comprehensive visualizations that capture multi-dimensional data
Use established data standards to enable comparison with other studies
Make data and models publicly available through appropriate repositories
This integrated approach combines multiple lines of evidence to build a robust functional model of the uncharacterized ypbF protein, compensating for limitations in any single methodology and identifying consistent patterns across diverse data types.
Several cutting-edge technologies are poised to revolutionize the characterization of uncharacterized proteins like ypbF:
AI-driven structural and functional prediction:
AlphaFold2 and RoseTTAFold for highly accurate structure prediction.
Deep learning algorithms that predict protein-protein interactions from sequence data.
Machine learning approaches that integrate multiple data types to predict protein function.
Single-cell technologies:
Single-cell transcriptomics to identify cell-to-cell variability in response to ypbF deletion.
Single-cell proteomics to detect rare events or subpopulations affected by ypbF.
Microfluidics-based approaches for high-throughput phenotypic screening of mutants.
Spatial biology approaches:
Super-resolution microscopy techniques for precise protein localization.
Spatial transcriptomics and proteomics to map the subcellular context of ypbF function.
Correlative light and electron microscopy to link protein localization with ultrastructural features.
Genome and protein engineering:
CRISPR-based saturation mutagenesis for comprehensive functional domain mapping.
Optogenetic and chemogenetic tools for temporal control of protein function.
Expanded genetic code incorporation to probe specific protein interactions and functions.
Systems biology integration:
Multi-omics data integration frameworks to build comprehensive functional models.
Whole-cell modeling approaches that can predict the systemic effects of protein deletion.
These technologies, when strategically combined, can significantly accelerate the process of characterizing ypbF and other uncharacterized proteins by generating and testing hypotheses at unprecedented scale and precision.
Comparative studies of ypbF across Bacillus species can reveal evolutionary patterns that provide crucial insights into its function:
Phylogenetic analysis approaches:
Construct comprehensive phylogenetic trees of ypbF homologs across the Bacillus genus and related genera.
Map sequence conservation patterns to identify functionally constrained regions.
Analyze rates of evolutionary change to identify signatures of selection.
Compare gene neighborhood conservation (synteny) across species to identify functional associations.
Functional comparison strategies:
Perform cross-species complementation experiments:
Express ypbF homologs from diverse Bacillus species in the B. subtilis ypbF deletion strain.
Test which homologs can restore wild-type phenotypes to identify functionally conserved elements.
Compare phenotypes of ypbF deletions across species:
Generate equivalent mutations in multiple Bacillus species.
Identify common versus species-specific phenotypes.
Analyze expression patterns across species:
Determine if ypbF homologs are regulated similarly in response to specific conditions.
Identify conserved versus species-specific regulatory mechanisms.
Structural biology integration:
Compare predicted or solved structures of ypbF homologs to identify conserved structural features.
Map sequence conservation onto structural models to identify potential functional sites.
Ecological context analysis:
Correlate the presence, absence, or variations of ypbF with species' ecological niches.
Test if ypbF function relates to specific environmental adaptations.
This evolutionary approach provides a powerful lens for understanding protein function by distinguishing between core conserved functions and species-specific adaptations, potentially revealing the fundamental role of ypbF in Bacillus biology.
Fully characterizing the function of ypbF could unlock several potential applications depending on its discovered properties:
Biotechnological applications:
If ypbF demonstrates enzymatic activity:
Development of novel biocatalysts for industrial processes
Engineering improved variants with enhanced stability or substrate specificity
Creation of biosensors based on ypbF activity or binding properties
If ypbF influences stress responses or protein secretion:
Research tools:
Development of ypbF-based research reagents:
Affinity tags based on binding properties
Reporter systems based on activity
Tools for studying specific cellular processes ypbF is involved in
Creation of knockout and modification strategies:
Genetic manipulation tools targeting pathways involving ypbF
Inducible systems for temporal control of related processes
Potential therapeutic applications:
If ypbF has antimicrobial properties:
Development of novel antibiotics targeting related proteins in pathogenic bacteria
Creation of antimicrobial peptides based on functional domains
If ypbF influences bacterial stress responses:
Identification of targets for antibiotic potentiators
Development of strategies to combat antibiotic resistance
The experimental approaches used in recombinant Bacillus subtilis CM66-P4' research, which demonstrated improved stress responses in aquatic livestock , could provide methodological frameworks for exploring similar applications if ypbF is found to influence stress tolerance or immune modulation.
The full spectrum of applications will ultimately depend on the specific molecular function discovered, highlighting the importance of comprehensive functional characterization of this uncharacterized protein.